QIAsprint Connect - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

Representative image of molecular diagnostics, market volatility, and leadership transition themes as Qiagen (NYSE: QGEN) approaches its new CEO appointment and Q1 2026 earnings, with investors closely watching QIAstat-Dx, QuantiFERON, and strategic review developments.

Read More

Healthcare Industry News

Qiagen (NYSE: QGEN) at a crossroads ahead of new CEO and Q1 2026 results

Qiagen (NYSE: QGEN) retail investor roadmap: strategic review, CEO search, 2026 product pipeline and what the May earnings call means for shareholders.

April 3, 2026

web analytics